Patel, 2018 - Google Patents
Exploring the role of the lipid phosphatase SHIP2 in systemic metabolism and vascular biologyPatel, 2018
View PDF- Document ID
- 3353159542663936692
- Author
- Patel P
- Publication year
External Links
Snippet
Metabolic dysregulation in the form of insulin-resistant type 2 diabetes mellitus leads to premature death and disability, primarily as a consequence of vascular dysfunction. This relates to accelerated atherosclerosis, diminished vascular repair and dysfunctional …
- 101710005389 INPPL1 0 title abstract description 182
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Chen et al. | The lncRNA Malat1 regulates microvascular function after myocardial infarction in mice via miR-26b-5p/Mfn1 axis-mediated mitochondrial dynamics | |
| Ji et al. | The ubiquitin E3 ligase TRAF6 exacerbates pathological cardiac hypertrophy via TAK1-dependent signalling | |
| Fukushima et al. | Sema3E-PlexinD1 signaling selectively suppresses disoriented angiogenesis in ischemic retinopathy in mice | |
| Han et al. | Deletion of Lkb1 in renal tubular epithelial cells leads to CKD by altering metabolism | |
| Mikula et al. | Embryonic lethality and fetal liver apoptosis in mice lacking the c‐raf‐1 gene | |
| Pang et al. | Mettl14 attenuates cardiac ischemia/reperfusion injury by regulating Wnt1/β-catenin signaling pathway | |
| Cui et al. | Angiopoietin/Tie2 pathway mediates type 2 diabetes induced vascular damage after cerebral stroke | |
| JP6565121B2 (en) | How to treat metabolic disorders | |
| Sadri et al. | Collagen type XIX regulates cardiac extracellular matrix structure and ventricular function | |
| Zhang et al. | An oxygen-insensitive Hif-3α isoform inhibits Wnt signaling by destabilizing the nuclear β-catenin complex | |
| Zhou et al. | AIFM1, negatively regulated by miR-145-5p, aggravates hypoxia-induced cardiomyocyte injury | |
| Xu et al. | ECSIT is a critical limiting factor for cardiac function | |
| Sheng et al. | The RING-domain E3 ubiquitin ligase RNF146 promotes cardiac hypertrophy by suppressing the LKB1/AMPK signaling pathway | |
| Fresco et al. | Fibulin-1 binds to fibroblast growth factor 8 with high affinity: effects on embryo survival | |
| Patel | Exploring the role of the lipid phosphatase SHIP2 in systemic metabolism and vascular biology | |
| Guo et al. | Tribbles homolog 3 is induced by high glucose and associated with apoptosis in human endothelial cells | |
| Nevado et al. | Role of insulin receptor and balance in insulin receptor isoforms A and B in regulation of apoptosis in simian virus 40-immortalized neonatal hepatocytes | |
| US20060142193A1 (en) | Selective inhibition of rock1 in cardiac therapy | |
| Musialowski | The role of endothelial glutamine synthetase in vascular tone and atherogenesis | |
| Zhang et al. | Prenatal liver is resistant to low glucose-induced inhibition of mTORC1 | |
| Peng et al. | ABCC9 knockdown attenuates isoproterenol-induced myocardial hypertrophy by inhibiting the PI3K/AKT signaling pathway | |
| Tong et al. | Rab26-mediated lysosomal translocation of eEF1A alleviates myocardial hypertrophy and cardiac remodeling | |
| Xu et al. | Inhibition of Bif-1 confers cardio-protection in myocardial infarction | |
| Ying | Role of STE20-Type Kinases in Liver Lipid Metabolism and Hepatocarcinogenesis: Insights from In Vitro and In Vivo Studies | |
| Derle | Elucidating the role of Phosphoinositide 3-Kinase-C2-Alpha in vesicular trafficking as well as in modulating glucose homeostasis |